Seres Therapeutics (Germany) Price Prediction
| 1S9 Stock | EUR 0.83 0.05 5.68% |
Oversold Vs Overbought
61
Oversold | Overbought |
Using Seres Therapeutics hype-based prediction, you can estimate the value of Seres Therapeutics from the perspective of Seres Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Seres Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Seres because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Seres Therapeutics after-hype prediction price | EUR 0.83 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Seres |
Seres Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Seres Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Seres Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Seres Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Seres Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Seres Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Seres Therapeutics' historical news coverage. Seres Therapeutics' after-hype downside and upside margins for the prediction period are 0.04 and 8.76, respectively. We have considered Seres Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Seres Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Seres Therapeutics is based on 3 months time horizon.
Seres Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Seres Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Seres Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Seres Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 7.93 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.83 | 0.83 | 0.00 |
|
Seres Therapeutics Hype Timeline
Seres Therapeutics is presently traded for 0.83on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Seres is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is presently at 0.26%. %. The volatility of related hype on Seres Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.83. About 86.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 2.18. Seres Therapeutics had not issued any dividends in recent years. Assuming the 90 days horizon the next estimated press release will be in 5 to 10 days. Check out Seres Therapeutics Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in Seres Stock please use our How to Invest in Seres Therapeutics guide.Seres Therapeutics Related Hype Analysis
Having access to credible news sources related to Seres Therapeutics' direct competition is more important than ever and may enhance your ability to predict Seres Therapeutics' future price movements. Getting to know how Seres Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Seres Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| OD7B | ETFS Coffee ETC | 0.00 | 0 per month | 1.76 | 0.20 | 4.90 | (3.28) | 14.00 | |
| 5GH | GUARDANT HEALTH CL | 0.00 | 0 per month | 2.33 | 0.16 | 8.18 | (4.90) | 20.42 | |
| FMW | FEMALE HEALTH | 0.00 | 0 per month | 0.00 | (0.06) | 7.69 | (5.17) | 19.09 | |
| 902 | ALEFARM BREWING DK 05 | 0.00 | 0 per month | 0.00 | (0.05) | 10.53 | (9.52) | 21.11 | |
| PO6 | Penta Ocean Construction Co | 0.00 | 0 per month | 1.42 | (0.08) | 2.15 | (2.56) | 7.36 | |
| 5EZ | SHIP HEALTHCARE HLDGINC | 0.00 | 0 per month | 1.56 | (0.06) | 2.33 | (2.19) | 8.82 | |
| DFA1 | DAIRY FARM INTL | 0.00 | 0 per month | 1.15 | 0.17 | 4.43 | (1.94) | 15.86 | |
| RMY | Ramsay Health Care | 0.00 | 0 per month | 0.00 | (0.08) | 2.63 | (2.50) | 6.87 |
Seres Therapeutics Additional Predictive Modules
Most predictive techniques to examine Seres price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Seres using various technical indicators. When you analyze Seres charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Seres Therapeutics Predictive Indicators
The successful prediction of Seres Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Seres Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Seres Therapeutics based on analysis of Seres Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Seres Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Seres Therapeutics's related companies.
Story Coverage note for Seres Therapeutics
The number of cover stories for Seres Therapeutics depends on current market conditions and Seres Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Seres Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Seres Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Seres Therapeutics Short Properties
Seres Therapeutics' future price predictability will typically decrease when Seres Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Seres Therapeutics often depends not only on the future outlook of the potential Seres Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Seres Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 91.9 M |
Complementary Tools for Seres Stock analysis
When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |